Commission Implementing Regulation (EU) 2025/150 of 29 January 2025 renewing the approval of the active substance mepiquat chloride in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011

Renewal of the approval of the active substance

Article 1

The approval of the active substance mepiquat chloride, as specified in Annex I to this Regulation, is renewed, subject to the conditions laid down in that Annex.

Amendments to Implementing Regulation (EU) No 540/2011

Article 2

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Entry into force and date of application

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union . It shall apply from 1 March 2025.

ANNEX ISupplementary provisions

ANNEX I Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions Mepiquat chloride CAS No: 24307-26-4 CIPAC No: 440.302 1,1-dimethylpiperidinium chloride ≥ 990 g/kg (theoretical dry technical material, TC) 615-665 g/L (technical concentrate, TK) The impurity N-methylpiperidine shall not exceed 3 g/kg (on theoretical dry weight basis) or 2 g/L (in the technical concentrate, TK). 1 March 2025 29 February 2040 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on mepiquat chloride, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the specification of the technical material as commercially manufactured; — the protection of operators, ensuring that conditions of use include the application of adequate personal protective equipment. Conditions of use shall include risk mitigation measures, where appropriate. ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.

ANNEX IISupplementary provisions

ANNEX II The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in Part A, entry 191 on mepiquat is deleted; (2) in Part B, the following entry is added: No Common Name, Identification Numbers IUPAC Name Purity  ( 1 ) Date of approval Expiration of approval Specific provisions ‘173 Mepiquat chloride CAS No: 24307-26-4 CIPAC No: 440.302 1,1-dimethylpiperidinium chloride ≥ 990 g/kg (theoretical dry technical material, TC) 615-665 g/L (technical concentrate, TK) The impurity N-methylpiperidine shall not exceed 3 g/kg (on theoretical dry weight basis) or 2 g/L (in the technical concentrate, TK). 1 March 2025 29 February 2040 For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on mepiquat chloride, and in particular Appendices I and II thereto, shall be taken into account. In this overall assessment Member States shall pay particular attention to: — the specification of the technical material as commercially manufactured; — the protection of operators, ensuring that conditions of use include the application of adequate personal protective equipment. Conditions of use shall include risk mitigation measures, where appropriate. ( 1 )   Further details on the identity and specification of the active substance are provided in the renewal report.’